Tejinder Pal Khaket

Tejinder Pal Khaket's research focuses on cancer biology, particularly on how cancer cells respond to stress and die, including processes like ferroptosis (an iron-dependent form of cell death), autophagy (a cellular self-degradation process), and mitochondrial dysfunction. Recent work examines combination drug therapies for cancers such as melanoma, thyroid cancer, and glioma, often targeting mutated genes like BRAFV600E alongside cell-death pathways to enhance treatment effectiveness. The work spans laboratory experiments in cell lines and preclinical models to identify potential drug combination strategies.

Publication output has increased notably in the most recent two years (2025-2026) after a period of lower, steady output earlier in the decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026